An improved Fc function assay utilizing CMV antigen-coated red blood cells generated with synthetic

T Georgakopoulos1, S Komarraju, S Henry

  • 1Research and Development Department, CSL Biotherapies, Broadmeadows, Vic., Australia.

Vox Sanguinis
|July 14, 2011
PubMed
Abstract

Related Concept Videos